Cue Biopharma (FRA:1UC0) FFO


FRA:1UC0 Cue Biopharma Inc FRA:1UC0
57 GF Score
Price €25.92
GF Value €51.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Cue Biopharma FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1UC0
57GF Score
Cue Biopharma Inc FRA:1UC0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cue Biopharma (FRA:1UC0) Overvalued in 2026?

Based on GuruFocus' analysis, Cue Biopharma stock appears to be undervalued. The current stock price of €25.92 is trading 49.2% below its estimated GF Value™ of €51.06. GuruFocus considers Cue Biopharma to be Possible Value Trap.

Key valuation signals for FRA:1UC0:

  • FFO:
  • GF Value™: €51.06 vs. price of €25.92 (49.2% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the FRA:1UC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cue Biopharma Business Description

Other Exchanges CUE:USA
Address 40 Guest Street, Boston, MA, USA, 02135
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
57GF Score

Get the complete analysis for FRA:1UC0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.92
Price
€51.06
GF Value